Does PharmaCare Intervénes With NursingCare

#DoesPharmaCareIntervénesWithNursingCare?

1. No, PharmaCare is the professional responsibility of PharmDs and does not intervene into NursingCare,  it complements it.

2. PharmaCare involves medication reconciliation, therapeutic review, dose optimization, interaction assessment, discharge medication planning, and patient counseling. 

3. These functions require specialized pharmacotherapy knowledge and are the core clinical responsibilities of PharmDs. 

4. This role ensures that every patient receives the most appropriate, safe, and effective medication therapy.

5. NursingCare, on the other hand, focuses on medication administration, bedside monitoring, and observing patient response. 

6. Nurses ensure that medications prescribed and reviewed under PharmaCare are correctly administered and that any clinical changes are promptly reported.

7. Thus, PharmaCare is the clinical domain of PharmDs, and NursingCare is the clinical domain of nurses. Both function collaboratively, not competitively. 

8. PharmaCare ensures medication correctness, and NursingCare ensures medication delivery and monitoring—together ensuring safe, accountable, and high-quality patient care. 

9. This  beings out comete triangular Collaborative support service with the patient in focus.

#MoHFW GoI

#AIPDA 

#APTI

#PharmD

POV: Bhagwan PS

Nursing care encompasses specialized medical and personal support provided by licensed nurses to individuals with acute or chronic health needs. These services, available in hospitals or at home, include wound care, medication management, vital sign monitoring, and rehabilitation. It focuses on enhancing patient independence, reducing recovery time, and offering emotional support. 

Core Components of Nursing Care

• Home Nursing Services: Licensed nurses provide 24/7 or hourly care for post-surgical recovery, elderly care, and chronic condition management, such as dementia or diabetes.
• Clinical Care Tasks: Involves complex procedures like IV fluid management, tracheostomy care, catheterization, injections, and wound dressing.
• Patient Education & Support: Educating patients and families about health conditions and providing emotional support. 

The Nursing Process (Framework for Care)
Nursing care is structured around a five-step, problem-solving approach: 

1. Assessment: Gathering patient data.
2. Diagnosis: Identifying the patient's health issues.
3. Planning: Setting measurable goals for recovery.
4. Implementation: Carrying out interventions.
5. Evaluation: Assessing effectiveness and modifying plans.

Benefits of Home Nursing Care

• Faster Recovery: Patients often heal better in the comfort of their homes.
• Reduced Risk: Decreases exposure to hospital-acquired infections.
• Convenience: Allows patients to maintain their daily routine while getting professional medical attention.
• Personalization: Tailored care plans focused on specific patient needs. 

Types of Nursing Interventions

• Independent: Actions based on nurse judgment, such as patient education and comfort measures.
• Dependent: Actions requiring physician orders, such as medication administration.
• Collaborative: Working with therapists, doctors, and specialists to manage care. 

Will Pharm-D course bringup such Pharmacovigilance Centers and Pharmaclinic Setups where FDI will be huge ?

Will Pharm-D course bringup such Pharmacovigilance Centers and Pharmaclinic Setups where FDI ( Foreign Direct Investment) will be huge ? 

Really ??? ... Not Confirmed...!!! 

Pharm.D (Doctor of Pharmacy) pass-outs in India operate in clinical setups as specialized clinical pharmacists, focusing on optimizing patient drug therapy, improving safety, and providing evidence-based medicine information. While they are trained to provide direct patient care, their role is currently most established in large corporate hospitals rather than in primary care, focusing on collaboration with physicians rather than independent prescribing. 

Key Clinical Roles and Practice Areas

• Ward Rounds Participation: Clinical pharmacists accompany doctors on rounds to provide input on drug selection, dosage adjustments, and potential drug interactions, particularly in specialty units like ICU, nephrology, oncology, and cardiology.
• Patient Medication Review: Analyzing medication charts to identify, prevent, or resolve drug-related problems (e.g., adverse drug reactions, therapeutic duplication, incorrect dosing).
• Patient Counseling: Educating patients on medication usage, side effects, lifestyle modifications, and proper adherence, particularly for chronic diseases.
• Drug Information Services: Providing evidence-based information on drugs to healthcare professionals and working in drug information centers to update the staff on new therapies.
• Pharmacovigilance (PV): Actively detecting, assessing, and reporting adverse drug reactions (ADRs) to improve medication safety. 

Practice Environment in India

• Hospital Setting: Mainly found in corporate hospitals (e.g., Apollo, Aditya Birla) where they are recognized as clinical pharmacists.
• Internship: The final year (6th year) involves internship or residency training in specialty units to develop direct patient care skills under supervision.
• Regulatory Status: Pharm.D is a registrable qualification under the Pharmacy Act, 1948.
• Challenges: The role is still evolving in India, with limited penetration in smaller hospitals and some resistance from other healthcare professionals. 

Differences from Other Roles

• Vs. B.Pharm: Pharm.D focuses on clinical patient-facing roles, whereas B.Pharm often focuses on industry and production.
• Vs. MBBS: Pharm.D graduates do not perform surgery or have the same diagnostic authority as medical doctors, although they work closely with them to advise on therapeutic strategies. 

I think this should be done" A bridge course for connecting Pharm D and MBBS". (SARCASM) Pharmacist A HealthCare professional? If so why pharmacy course is not?. Has the Pharmacy education been got included in National Health Education Manual?

I think this should be done : " A bridge course for connecting Pharm D and MBBS". This shall allow to produce talents and experts who have amalgamated, comprehensive  knowledge of  all the 3 most important aspects of healthcare which are medicine( for diagnosis of disease), pharmacy( for authentic knowledge of medications for prescription writing) and surgery (of course for operations). This has to definitely improve  and enhance quality of patient-care manyfolds . Why we shall always follow USA or western setups of education and service systems? They are good no doubt, as they are rich countries with large budgets for healthcare; but sometimes we must take initiatives and become leaders and provide path-breaking or a new-path setting grounds for others to follow.
Therefore I wrote a mail to secretory of MCI (secretary@mciindia.org), requesting for the same. It goes as follows:

Respected Sir/Madam,

I am currently pursuing 2nd year of PharmD (Post baccalaureate), which is a relatively a new curriculum started by PCI since 2008 and which is clinically oriented pharmacy. Up till now pharmacy in India was industry oriented i.e. pharmacist was more into manufacturing,sales,research of discovery of novel molecules and invention of formulations etc.But now with the advent of PharmD, it has become clinically oriented i.e. now a pharmacist is given an opportunity, allowed and equipped to play a role in direct patient care, giving pharmaceutical care. 
Madam, PharmD syllabus framed by PCI contains many pharmacy related subjects along with the subjects which are present in common in both MBBS and PharmD curriculum, i.e. subjects like anatomy and physiology (a lot lesser of it is there in PharmD), Pathophysiology, Biochemistry, Microbiology, Pharmacology, Biopharmaceutics (a lot more of it is there in PharmD). 
Madam, I have a great respect for MBBS course and for physicians and surgeons. And I am currently 29 year old man. This is to ask you whether its feasible/ possible that a new course/curriculum may be framed and started by MCI within two to three years, which can bridge this gap between PharmD and MBBS.That is, a bridge-course(of 3years duration) which shall allow a PharmD graduate to be certified as MBBS,upon successfully completion of such a course. This may bring a new input, perspective and vision in patient care, to MBBS/physician as well as provide an opportunity, encourage, help fulfil dreams and strong aspirations of human beings like me, who wish to study such a curriculum, get a medical license, be a physician and earnestly want to play that very role in the healthcare system, at this stage and age of our lives.  
May all this come into effect for the 2014-2015 session.

Hoping for an encouraging, enlightening and positive reply on this request from you.

Yours truly,

Samrat Paul

Pharmacist A HealthCare professional? If so why pharmacy course is not?.

Has the Pharmacy education been got included in National Health Education Manual?

Yes, Pharmacy is included in the national health education framework in India, particularly through the initiatives of the Pharmacy Council of India (PCI) and its alignment with national health policies. 

Key details regarding the inclusion of pharmacy in national health education include:

• Revised Curriculum: The Bachelor of Pharmacy (B. Pharm) and Diploma in Pharmacy (D. Pharm) curricula are aligned with the National Education Policy (NEP) 2020, focusing on integrating pharmaceutical sciences with healthcare demands.
• Public Health Roles: Pharmacists are recognized for their role in National Health Programs (NHPs) such as HIV/AIDS awareness, tobacco control, and tuberculosis control (RNTCP).
• Competency-Based Training: The Education Regulations 2020 for the D. Pharm course (approved by the PCI) focus on professional training, and the PCI has implemented an Exit Examination to ensure standard quality among graduates.
• Patient Counseling: The curriculum emphasizes "Health Education and Community Pharmacy," aiming to educate students on public health, patient counseling, and medication safety. 

In addition, pharmacists are considered vital members of the healthcare team, and their role is increasingly recognized within the Indian Public Health Standards (IPHS) for health facilities. 

When pharmacy is included in national health education manual ?

Pharmacy was formalized in the national education framework of India with the enactment of the Pharmacy Act in 1948, which established the first minimum standards of educational qualification for pharmacy practice. 

Key developments in the inclusion and evolution of pharmacy in national education include:

• 1948 (Pharmacy Act): Established to regulate the profession and education, creating the Pharmacy Council of India (PCI).
• Pharm.D. Regulations 2008: Introduced a six-year Pharm.D. program to integrate clinical pharmacy into healthcare.
• Education Regulation 2020: Updated the diploma course curriculum (ER-2020) and mandated specific staff-to-student ratios for B.Pharm and D.Pharm courses.
• NEP 2020 Alignment: The Bachelor of Pharmacy (B.Pharm) curriculum is currently designed in alignment with the National Education Policy (NEP) 2020 to focus on outcomes-based education. 

Social Pharmacy was notably introduced into the D.Pharm Part-I syllabus, aligning pharmacy education with public health needs. 

Pharmacy is officially included in Indian national health education, curriculum, and public health standards through the Pharmacy Act of 1948, which established the Pharmacy Council of India (PCI) to regulate the profession. 

Key milestones for the inclusion of pharmacy in national health education and guidelines include:

• 1948 (Pharmacy Act): Set the first minimum standard of educational qualification for pharmacy practice.
• 2007/2012 (Indian Public Health Standards - IPHS): Pharmacy services were integrated into public health facilities (PHCs, CHCs, etc.), establishing the role of pharmacists in the national health delivery system.
• Education Regulation (ER) 2020/2021: Updated by the PCI to align with modern educational standards, specifically for diploma courses and, more recently, aligning B.Pharm curricula with the National Education Policy (NEP) 2020 to focus on health, industry, and technology.
• National Health Policy 2017: Emphasized the strengthening of the health system by 2020–2025, which includes the integration of pharmacists in primary care. 

Contextual Inclusion:
Pharmacy studies in India, such as B.Pharm and D.Pharm, include comprehensive curricula on health education, community pharmacy, and national health programs. Furthermore, the Indian Pharmaceutical Association (IPA) has recommended the inclusion of specialized "Pharmaceuticals" sub-chapters in national policies to address pharmacists' roles in drug regulation and quality control. 

Pharmacy was formally and legally included as a regulated profession in India through the Pharmacy Act of 1948, which established the Pharmacy Council of India (PCI) to set minimum educational qualifications for pharmacy practice. While pharmacy education existed earlier, the 1948 Act provided the foundation for incorporating pharmacy into national health education and services. 

Key milestones for the inclusion of pharmacy in national education and public health include:

• 1948 – The Pharmacy Act: The primary legislation that established minimum standards of education, formalizing the training required for pharmacy practice.
• 1991 – Revision of D.Pharm Syllabus: The Education Regulations (ER) framed in 1991 standardizes the Diploma in Pharmacy curriculum nationwide.
• 1996–1997 – Clinical Pharmacy Introduction: M.Pharm programs in pharmacy practice were introduced at JSS College of Pharmacy to shift focus from product to patient-centered services.
• 2008 – Introduction of Pharm.D: The 6-year Doctor of Pharmacy (Pharm.D) program was introduced, marking a significant, formal integration of pharmacists into clinical settings and patient care.
• 2020 – National Education Policy (NEP) & ER-2020: Pharmacy education has been updated to align with the NEP 2020, focusing on skill-based learning. Furthermore, the D.Pharm Education Regulations 2020 (ER-2020) replaced the 1991 syllabus to align with modern community pharmacy practice. 

Key Inclusion in Health Education and Public Health:

• Health Education and Community Pharmacy: This subject was integrated into the diploma curriculum, focusing on education in nutrition, family planning, and communicable diseases.
• National Health Programs (NHPs): Recently, pharmacists are formally being included in national initiatives, such as the National Health Mission (NHM) and the National TB Elimination Program (NTEP), strengthening their role in community health. 

Bariatric Surgery

Weight loss (bariatric) surgery, such as gastric sleeve, gastric bypass, or banding, helps individuals with severe obesity (typically BMI 

$$

 or 

$$

) lose weight by restricting food intake or reducing nutrient absorption. These procedures frequently resolve obesity-related conditions like type 2 diabetes and hypertension. 

Common Types of Weight Loss Surgery

• Sleeve Gastrectomy (Gastric Sleeve): Removes a large portion of the stomach, leaving a banana-shaped sleeve that restricts food intake.
• Gastric Bypass (Roux-en-Y): Creates a small stomach pouch and connects it directly to the small intestine, bypassing part of the stomach and small intestine to reduce both intake and calorie absorption.
• Adjustable Gastric Band: A ring with an inflatable band is placed around the top of the stomach to limit food intake.
• Biliopancreatic Diversion with Duodenal Switch: A complex procedure combining, a smaller stomach pouch with a substantial reduction in nutrient absorption. 

Eligibility Criteria

• BMI of 40 or higher, or a BMI of 35-39.9 with serious obesity-related comorbidities (e.g., diabetes, sleep apnea).
• Some guidelines suggest a BMI of 27.5-32.5+ for the Asian Indian population with comorbidities.
• Recommended when other weight-loss methods like diet, exercise, or medication have failed. 

Benefits and Results

• Significant Weight Loss: Patients often experience significant and sustained weight loss.
• Health Improvement: High rates of improvement or reversal of type 2 diabetes, high blood pressure, and sleep apnea.
• Enhanced Metabolism: Many procedures alter hormone levels to decrease hunger and increase fullness. 

Risks and Considerations

• Requires lifelong dietary changes and nutritional supplements to prevent deficiencies.
• Risks can include bleeding, infection, blood clots, or long-term issues like dumping syndrome or hernia.
• Requires comprehensive pre-operative evaluation and long-term follow-up care. 

Procedure Techniques
Most surgeries are performed using minimally invasive techniques, such as laparoscopy (small incisions, camera) or robotics, which offer quicker recovery times

Approved Drug Products with Therapeutic Equivalence Evaluations( Orange Book)

Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book, is a publication produced by the United States Food and Drug Administration (FDA), as required by the Drug Price and Competition Act (Hatch-Waxman Act).

The Hatch-Waxman Act was created to '"strike a balance between two competing policy interests:

1. inducing pioneering research and development of new drugs and
2. enabling competitors to bring low-cost, generic copies of those drugs to market'".^[1]

The Orange Book identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act. The publication does not include drugs on the market approved only on the basis of safety (covered by the ongoing Drug Efficacy Study Implementation [DESI] review [e.g., Donnatal Tablets and Librax Capsules] or pre-1938 drugs [e.g., Phenobarbital Tablets]). The main criterion for the inclusion of any product is that the product is the subject of an application with an effective approval that has not been withdrawn for safety or efficacy reasons. Inclusion of products on the List is independent of any current regulatory action through administrative or judicial means against a drug product.

In addition, the Orange Book contains therapeutic equivalence evaluations (2 character rating codes) for approved multisource prescription drug products (generic drugs). These evaluations have been prepared to serve as public information and advice to state health agencies, prescribers, and pharmacists to promote public education in the area of drug product selection and to foster containment of health care costs.^[2] Therapeutic equivalence evaluations in this publication are not official FDA actions affecting the legal status of products under the Act.

Finally, the Orange Book lists patents that are purported to protect each drug. Patent listings and use codes are provided by the drug application owner, and the FDA is obliged to list them. In order for a generic drug manufacturer to win approval of a drug under the Hatch-Waxman Act, the generic manufacturer must certify that they will not launch their generic until after the expiration of the Orange Book-listed patent, or that the patent is invalid, unenforceable, or that the generic product will not infringe the listed patent.

The Orange Book does not list biological products such as vaccines. These are listed in later-enacted Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations, commonly known as the Purple Book.^[3]

The DrugPatentWatch website offers a "Free DrugPatentWatch Orange Book PDF Library" from which the public can download digital copies of every FDA Orange Book, from the 1st Edition in 1980 to the most recent (as of 2020)

B. Pharm (Honours)

A Bachelor of Pharmacy (Honours) is a 4-year undergraduate degree, often spanning 8 semesters, that offers specialized, research-oriented training in pharmaceutical sciences beyond the standard curriculum. It prepares students for careers in drug R&D, clinical research, and pharmacy practice, with enhanced training in areas like pharmacovigilance and biotechnology.

Key Details for B.Pharm Honours:

• Duration & Structure: 4 years (8 semesters). Includes core subjects like Pharmaceutics, Pharmaceutical Chemistry, Pharmacology, and Pharmacognosy, often with an added research-focused "honours" subject or dissertation project.
• Eligibility: Typically requires 10+2 with a minimum of 50-60% marks in Physics, Chemistry, and Biology/Mathematics.
• Key Differences (Hons. vs Regular): Often involves more intensive practical training, in-hand knowledge via research projects, and specialized elective choices.
• Career Opportunities: Graduates find roles in R&D, Clinical Trials, Formulation Development, and Regulatory Affairs in top companies like Sunpharma, Cipla, and Dr. Reddy's.
• Top Institutions (India): BITS Pilani, Jamia Hamdard, and various specialized Pharmacy Colleges approved by the PCI (Pharmacy Council of India). 

• Pharmaceutics: Drug manufacturing and formulation.
• Pharmacology: Effects of medicine on the human body.
• Medicinal Chemistry: Chemical composition of drugs.
• Pharmacognosy: Natural sources of medicines.
• Biopharmaceutics & Pharmacokinetics: Body’s interaction with drugs. 

Yes, B.Pharm Honours (B.Pharm Hons) is different from a regular B.Pharm (Bachelor of Pharmacy), primarily in depth, curriculum, and research focus. While both are 4-year undergraduate courses, Hons offers specialized, in-depth study, including extra specialized subjects, advanced research techniques, and higher eligibility requirements. 

Key Differences Between B.Pharm Hons and Regular B.Pharm

• Curriculum Depth: B.Pharm Hons dives deeper into subjects like drug formulation, advanced pharmacology, and research techniques compared to the standard B.Pharm, which provides a broader overview.
• Specialized Subjects: B.Pharm Hons curricula often include specialized subjects or extra subjects (e.g., from MOOCS). It emphasizes advanced laboratory work and research projects, focusing heavily on drug discovery and development.
• Academic Rigor: Honours degrees typically require higher academic performance, often requiring higher percentages in qualifying examinations for admission.
• Focus & Research: B.Pharm Hons is often designed for students aiming for research, development, or high-end academia within the pharmaceutical field.
• Job Opportunities: While both offer good career paths, B.Pharm Hons graduates may have an edge in specialized research roles (R&D) in pharmaceutical companies due to their deeper knowledge and practical experience.

Comparison Table

Feature	B.Pharma (Hons)	Regular B.Pharma
Duration	4 Years	4 Years
Focus	In-depth and Specialized	Broad and Analytical
Curriculum	Extra/Specialized Subjects	Standardized Curriculum
Academic Requirement	High (High Percentage)	Moderate (High School Science)
Career Aim	Research/Development	Regulatory/Manufacturing

Both courses are 4-year undergraduate programs with eight semesters, preparing students for careers in pharmacy and pharmaceuticals

About B.Pharm (Hons.)

B.Pharm (Hons.) is a four-year undergraduate course. The course deals with the study to understand the properties and impacts of medicines and developing the skills required to counsel patients about their use. B.Pharm Hons. covers all facets of healthcare including biochemical areas that concern the preparation of medicines and implementing them for the right diagnosis which is essential to build a successful career as a Pharmacist or for other related fields.

What makes B.Pharm (Hons.) course so popular is that apart from traditional pharmacy course is that one tends to learn about Operations, Sales and Marketing in the Pharmacy field which opens up multiple job opportunities.

B.Pharm (Hons.) Course Highlights

Check out the B.Pharm (Hons.) course highlights.

Category	Highlights
Course Name	B.Pharm (Hons.)
Duration	4 Years
Exam Type	Semester
Annual Course Fee	?15,000 - ?1,25,000
Average Initial Salary	?2,00,000 - ?3,00,000 LPA
Employment Sectors	Government/Private Hospitals, Clinical Pharmacy, Medical Dispensaries, etc.

B.Pharm (Hons.) Eligibility Criteria

Candidates need to fulfil the following eligibility criteria in order to get admission in B.Pharm (Hons.) course.

• Candidates should have passed Class 12th examination with minimum 60% marks from any recognized board

• Candidates should have secured three diploma programs in pharmacy and can also apply for B.Pharm (Hons.) courses.

• Candidates who hold a 3 or 2 years diploma degree after their class 10th examination can also apply for admissions.

• The candidates should be minimum of 17 years of age at the time of admission

B.Pharm (Hons.) Admission Process 2020

Admission to the B.Pharm (Hons.) courses is done on the basis of candidates performance in the entrance examination. Some of the popular B.Pharm (Hons.) entrance exams include BITSAT, WBJEE. However, certain institutes consider 10+2 marks for admissions.

B.Pharm (Hons.) Course Fee

The B.Pharm (Hons.) course fee varies from institution to institution. The average course fee of the course at Government and Private colleges (annually) is as follows:

Type	Minimum Fee	Maximum Fee
Government College	Rs 5,000/-	Rs 30,000/-
Private College	Rs 50,000/-	Rs 1,25,000/-

Show Less

B.Pharm (Hons.) Syllabus

Some of the major topics that are taught in B.Pharm (Hons.) is mentioned below:-

S.No.	Major Topics to Study
1	Inorganic Pharmaceutical Chemistry-I
2	Organic Pharmaceutical Chemistry-1
3	Physical Pharmacy-I
4	Pharmacognosy-I
5	Physiology and Biochemistry-1
6	Pharmaceutical Microbiology and Immunology
7	Biostatistics and Computer Science
8	English (Noncredit)1
9	Practical2
10	Viva-Voce (General)
11	Class assessment/ tutorial/ home assignment/ attendance 3
12	Inorganic Pharmaceutical Chemistry-II
13	Organic Pharmaceutical Chemistry-II
14	Physical Pharmacy-II
15	Pharmacognosy-II
16	Physiology and Biochemistry-II
17	Pharmacology-I
18	Pharmaceutical Technology-I
19	Practical 2
20	Viva-Voce (General) II
21	Pharmaceutical Analysis-I
22	Medicinal Chemistry-I
23	Pharmacology-II
24	Biopharmaceutics-I
25	Pharmaceutical Engineering
26	Pharmaceutical Technology-II
27	Cosmetology
28	Hospital and Community Pharmacy
29	Quality Control, Quality Assurance & Validation
30	Class assessment/ tutorial/ home assignment/ attendance III
31	Pharmaceutical Analysis-II
32	Medicinal Chemistry-II
33	Pharmacology-III
34	Biopharmaceutics-II
35	Pharmaceutical Technology-III
36	Molecular Biology and Biotechnology
37	Organic Spectroscopy
38	Clinical Pharmacy and Pharmacy Law & Ethics
39	Pharmaceutical Marketing and Management
40	Practical IV
41	Viva-Voce (General) IV
42	Class assessment/ tutorial/ home assignment/

Show Less

B.Pharm (Hons.) Career Options and Job Prospects

After completing B.Pharm (Hons.), students can work in various fields in the pharmacy sector. They can also open their own pharmacy store by registering it under the State Pharmacy Council. Some of the well-known employment sectors and job profiles that candidates can take up after pursuing B.Pharm (Hons.) course are as follows:

Employment Sectors	Food and Drug Administration Sales and Marketing Department Educational Institutes Health Centres Hospital Pharmacy Clinical Pharmacy Technical Pharmacy Research Agencies Medical Dispensing Store
Job Profiles	Drug Therapist Hospital Drug Coordinator Food and Drug Inspector Analytical Chemist Drug Inspector Medical Transcriptionist Lecturer & Professor Researcher Retailing Supervisor Teacher
Average Salary	Rs 2,00,000/- to Rs 3,50,000/- LPA

Show Less

Telling Dose Vs Optimizing Dose

#TellingDoseVsOptimizingDose

Morning dose - Till 12 noon

Afternoon - 12 noon to 6pm

Night dose - Before 12 AM

1. That is the unfortunate reality. In India, “dose” is often reduced to instructions like one tablet twice daily, before food or after food. It is treated as a schedule, not as a scientifically individualized quantity.

2.  The deeper meaning of dose—how much exactly this patient needs, based on their physiology, disease state, organ function, and concurrent therapy—is rarely examined.

3. True dose optimization goes far beyond timing. It asks critical questions:

👉 Is the patient’s kidney clearing the drug normally? 

👉 Is the liver metabolizing it efficiently?

👉 Is the body weight appropriate for the standard dose? 

👉 Is the drug reaching therapeutic concentration?

👉 Is the patient elderly, pediatric, critically ill, or on interacting medicines? 

4  Without answering these, giving “one tablet twice daily” becomes a ritual, not rational therapy.

5. Optimization is the science of precision. 

6. Optimization prevents toxicity when the dose is too high and prevents treatment failure when the dose is too low. 

7. Optimization converts prescribing from habit to accountability.

8. In India, timing is emphasized because it is easy to instruct and easy to follow. 

9. Optimization is neglected because it requires measurement, documentation, expertise, and ownership. 

10 Until healthcare formally assigns responsibility for dose optimization—supported by clinical pharmacology services and PharmD professionals—dose will continue to mean frequency, not precision.

11  And that is the difference between giving a medicine and managing drug therapy scientifically.

POV: Bhagwan PS